Active Ingredient History

NOW
  • Now
Relugolix, sold under the brand names Orgovyx and Relumina and as one component of Myfembree, is a gonadotropin-releasing hormone antagonist medication which is used in the treatment of prostate cancer in men and uterine fibroids in women. It is also under development for use in the treatment of endometriosis. It is taken by mouth once per day.   Wikipedia

  • SMILES: CONC(=O)Nc1ccc(cc1)c2sc3N(Cc4c(F)cccc4F)C(=O)N(C(=O)c3c2CN(C)C)c5ccc(OC)nn5
  • InChIKey: AOMXMOCNKJTRQP-UHFFFAOYSA-N
  • Mol. Mass: 623.64
  • ALogP: 3.75
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( relugolix, estradiol (progynon depot), norethindrone - other name: relugolix/e2/neta fdc )
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea | relugolix | tak385 | tak 385 | tak-385

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue